SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emil Chiauzzi, Gabriel Eichler, Paul Wicks, Oncology Informatics, 2016,

    CrossRef

  2. 2
    Isabelle Bedrosian, Yu Shen, Breast conserving therapy or mastectomy: a done deal or one worth returning to?, Journal of Comparative Effectiveness Research, 2015, 4, 3, 187

    CrossRef

  3. 3
    Christina DeFilippo Mack, M. Alan Brookhart, Robert J. Glynn, Anne Marie Meyer, William R. Carpenter, Robert S. Sandler, Til Stürmer, Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults, Epidemiology, 2015, 26, 5, 690

    CrossRef

  4. 4
    Adam J. Olszewski, Eric S. Winer, Jorge J. Castillo, Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base, Cancer Causes & Control, 2015, 26, 8, 1163

    CrossRef

  5. 5
    Anne-Marie Meyer, Stephanie B. Wheeler, Morris Weinberger, Ronald C. Chen, William R. Carpenter, An Overview of Methods for Comparative Effectiveness Research, Seminars in Radiation Oncology, 2014, 24, 1, 5

    CrossRef

  6. 6
    William F. Lawrence, Comparative Effectiveness Research in Practice and Policy for Radiation Oncology, Seminars in Radiation Oncology, 2014, 24, 1, 54

    CrossRef

  7. 7
    Bradford R. Hirsch, S. Yousuf Zafar, Comparative Effectiveness Research: Moving Medical Oncology Forward, Seminars in Radiation Oncology, 2014, 24, 1, 49

    CrossRef

  8. 8
    David J. Sher, Rinaa S. Punglia, Decision Analysis and Cost-Effectiveness Analysis for Comparative Effectiveness Research—A Primer, Seminars in Radiation Oncology, 2014, 24, 1, 14

    CrossRef

  9. 9
    Jeffrey Peppercorn, S Yousuf Zafar, Kevin Houck, Peter Ubel, Neal J Meropol, Does comparative effectiveness research promote rationing of cancer care?, The Lancet Oncology, 2014, 15, 3, e132

    CrossRef

  10. 10
    Alan J. Ó Céilleachair, Paul Hanly, Máiréad Skally, Ciaran O’Neill, Patricia Fitzpatrick, Kanika Kapur, Anthony Staines, Linda Sharp, Cost Comparisons and Methodological Heterogeneity in Cost-of-illness Studies, Medical Care, 2013, 51, 4, 339

    CrossRef

  11. 11
    Wayne Laurence Monsky, Chris Molloy, Bedro Jin, Timothy Nolan, Dayantha Fernando, Shaun Loh, Chin-Shang Li, Quality-of-Life Assessment After Palliative Interventions to Manage Malignant Ureteral Obstruction, CardioVascular and Interventional Radiology, 2013, 36, 5, 1355

    CrossRef

  12. 12
    Tami L Mark, William Lawrence, Rosanna M Coffey, Timothy Kenney, Bong Chul Chu, Emile R Mohler, Claudia Steiner, The value of linking hospital discharge and mortality data for comparative effectiveness research, Journal of Comparative Effectiveness Research, 2013, 2, 2, 175

    CrossRef

  13. 13
    Sumit Gupta, Jason D Pole, Astrid Guttmann, Lillian Sung, Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia, BMC Medical Research Methodology, 2013, 13, 1, 68

    CrossRef

  14. 14
    William R. Carpenter, Anne-Marie Meyer, Amy P. Abernethy, Til Stürmer, Michael R. Kosorok, A framework for understanding cancer comparative effectiveness research data needs, Journal of Clinical Epidemiology, 2012, 65, 11, 1150

    CrossRef